Professor25/iStock via Getty Images
- DBV Technologies (NASDAQ:DBVT) stock shot up 29% in post-market trading Wednesday after the company said it has aligned with the FDA on an accelerated approval pathway for its peanut allergy patch Viaskin for children aged one to three years.
- The